13F Pro Quality Score

24.3/100

Rank #2,588 of 2,879 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

44.7/100

Profitability

7.0/100

Balance Sheet

4.6/100

Earnings Quality

30.0/100

Free Cash Flow

19.7/100

Institutional Flow

5.8/100

Revenue Scale

45.7/100

Dilution Risk

34.0/100

TLRY Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Tilray Brands, Inc. (TLRY), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores TLRY at 24.3/100 on a 32-signal composite quality model, placing it at rank #2,588 of 2,879 stocks — the bottom half of the AI-ranked universe. Areas of concern include balance sheet strength (4.6) and institutional flow (5.8), which score below median versus the broader universe. Shareholder dilution risk is elevated at 34.0/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q3 2026), Tilray Brands, Inc. reports quarterly revenue of $206.7M, net income of $-26.6M, free cash flow of $-21.9M. Top institutional holders of TLRY by reported 13-F value include Graham Capital Management, L.P., SUSQUEHANNA INTERNATIONAL GROUP, LLP, DeepCurrents Investment Group, based on the most recent SEC filings. TLRY trades on the Nasdaq exchange and files with the SEC under CIK 1731348. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate TLRY daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Tilray Brands, Inc. directly from SEC EDGAR. Tilray Brands, Inc.'s 13F Pro composite quality score has ranged between 8 and 51 since 2022, currently 24.3 — a declining long-term trajectory across 52 quarterly and live scoring snapshots.

Revenue

Q3 2026

$206.7M

Net Income

Q3 2026

$-26.6M

Free Cash Flow

Q3 2026

$-21.9M

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+4.1% YoY
$821.3MFY 2025
FY22 $628.4MFY23 $627.1MFY24 $788.9MFY25 $821.3M

Net Income

-792.6% YoY
$-2.19BFY 2025
FY22 $-476.8MFY23 $-1.45BFY24 $-245.0MFY25 $-2.19B

Operating Income

-1206.3% YoY
$-2.28BFY 2025
FY22 $-610.4MFY23 $-1.37BFY24 $-174.7MFY25 $-2.28B

EPS (Diluted)

-645.5% YoY
$-2.46FY 2025
FY22 $-0.99FY23 $-2.35FY24 $-0.33FY25 $-2.46

Total Assets

-50.9% YoY
$2.07BFY 2025
FY22 $5.45BFY23 $4.31BFY24 $4.22BFY25 $2.07B

Total Debt

-60.2% YoY
$7.2MFY 2025
FY22 $271.6MFY23 $23.4MFY24 $18.0MFY25 $7.2M

Op. Cash Flow

-206.1% YoY
$-94.6MFY 2025
FY22 $-177.3MFY23 $7.9MFY24 $-30.9MFY25 $-94.6M

Get alerted when TLRY's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Tilray Brands, Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of TLRY

Put TLRY on your watchlist

Track score changes the day Tilray Brands, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is TLRY a good stock to buy?

13F Pro's AI-powered analysis of Tilray Brands, Inc. (TLRY) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for TLRY are available on the TLRY stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own TLRY?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling TLRY. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Tilray Brands, Inc.'s investment landscape.